Abstract:Background: Atrial fibrosis serves as a disease initiating mechanism in the develop-ment of atrial fibrillation. Angiotensin II (Ang-II), a key mediator for atrial fibrosis, aberrantly activates atrial fibroblasts (AFs) into myofibroblasts, resulting in subsequent excessive synthesis and deposition of extracellular matrix (ECM). Cadherin-11 (CDH11) is essential in the development of non-cardiac fibrotic diseases. In this study, we investigated its role in the pathogenesis and underlying mechanism of atrial fibrillation. Methods: We obtained left atrial tissues from either patients with atrial fibrillation or Ang-II-induced atrial fibrosis mice. We utilized a global CDH11 knockout mouse (CDH11(-/-)) model to determine the effect of CDH11 on AF cell proliferation, migration, ECM synth-esis/deposition. RNA-Seq of isolated AFs from CDH11(-/-) or normal mice was performed and differential expressed genes were analyzed. The mouse susceptibility to atrial fibrillation was examined by cardiac electrophysiology. Results: We found that cadherin-11 was significantly up-regulated in fibrotic atrial tissue from patients with atrial fibrillation and Ang-II-induced mice. Both normal and CDH11(-/-) mice did not develop atrial fibrosis at resting state. However, after Ang-II infusion, unlike severe atrial fibrosis occurred in normal mice, CDH11(-/-)mice displayed a reduced atrial fibrosis. Atrial fibroblasts with CDH11 deletion from CDH11(-/-)mice showed reduction in Ang-II-induced cell proliferation, migration and ECM synthesis/deposition, indicating the involvement of CDH11 in atrial fibrosis. Consistently, RNA-Seq of CDH11-null AFs uncovered significant decrease in pro-fibrotic gene expression. In addition, we identified reduction of transcripts associated with Smad2/3, ERK1/2 and JNK pathways. Further, CDH11(-/-)mice showed a significantly attenuated Ang-II-induced susceptibility to atrial fibrillation. Conclusion: Our results indicate that CDH11 potentiates Ang-II-induced activation of AFs. The pathogenesis of atrial fibrosis is through CDH11 mediated stimulation of Smad2/3, ERK1/2 and JNK pathways. Thus, CDH11 might serve as a novel therapeutic target for ameliorating the development of atrial fibrillation.

MFGE8 Attenuates Ang-II-induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation Through Inhibition of TGF-β1/Smad2/3 Pathway

Restoration of Circulating MFGE8 (milk Fat Globule-EGF Factor 8) Attenuates Cardiac Hypertrophy Through Inhibition of Akt Pathway

Fibroblast Growth Factor 21 Protects Against Atrial Remodeling Via Reducing Oxidative Stress.

Ang II Enhances Atrial Fibroblast Autophagy and Promotes Atrial Remodeling Through the AT1-ERK-mTOR Signaling Pathway

FGF23 Regulates Atrial Fibrosis in Atrial Fibrillation by Mediating the STAT3 and SMAD3 Pathways

Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.

Liraglutide inhibits AngII-induced cardiac fibroblast proliferation and ECM deposition through regulating miR-21/PTEN/PI3K pathway

Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation Via TGF-β1/Smad2/α-SMA Pathway

Novel Role of the Clustered Mir‐23b‐3p and Mir‐27b‐3p in Enhanced Expression of Fibrosis‐associated Genes by Targeting TGFBR3 in Atrial Fibroblasts

Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.

Linggui Qihua Decoction Inhibits Atrial Fibrosis by Regulating TGF- β 1/Smad2/3 Signal Pathway

EZH2 As a Novel Therapeutic Target for Atrial Fibrosis and Atrial Fibrillation

Macrophage Migration Inhibitory Factor Promotes Cardiac Fibroblast Proliferation Through the Src Kinase Signaling Pathway

Paeoniflorin Inhibits Atrial Fibrosis and Atrial Fibrillation in Angiotensin II-Infused Mice Through the PI3K-Akt Pathway

The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation

Ethyl Ferulate suppresses Post-Myocardial Infarction Myocardial Fibrosis by Inhibiting Transforming Growth Factor Receptor 1

AT1 Receptor‐specific Down‐regulation of Smad7 Plays a Key Role in Atrial Fibrillation‐Induced Myocardial Fibrosis

Downregulation of fibromodulin attenuates inflammatory signaling and atrial fibrosis in spontaneously hypertensive rats with atrial fibrillation via inhibiting TLR4/NLRP3 signaling pathway

Cadherin-11 Deficiency Attenuates Ang-II-Induced Atrial Fibrosis and Susceptibility to Atrial Fibrillation

Inhibitory Effects of Propylene Glycol Alginate Sodium Sulfate Derivatives on Atrial Fibrosis in Atrial Fibrillation

Circ_0079480 facilitates proliferation, migration and fibrosis of atrial fibroblasts in atrial fibrillation by sponing miR-338-3p to activate the THBS1/TGF-β1/Smad3 signaling